Filing Details

Accession Number:
0001567619-20-014921
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-12 16:32:59
Reporting Period:
2020-08-10
Accepted Time:
2020-08-12 16:32:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1444380 Nevro Corp NVRO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1174533 F Michael Demane C/O Nevro Corp.
1800 Bridge Parkway
Redwood City CA 94065
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-10 30,469 $134.34 401,039 No 4 S Direct
Common Stock Disposition 2020-08-10 19,785 $135.58 381,254 No 4 S Direct
Common Stock Disposition 2020-08-10 24,208 $136.18 357,046 No 4 S Direct
Common Stock Disposition 2020-08-10 3,813 $138.44 353,233 No 4 S Direct
Common Stock Disposition 2020-08-10 2,337 $138.87 350,896 No 4 S Direct
Common Stock Disposition 2020-08-10 2,828 $140.11 348,068 No 4 S Direct
Common Stock Disposition 2020-08-10 1,626 $134.42 40,928 No 4 S Indirect See footnote
Common Stock Disposition 2020-08-10 1,474 $135.64 39,454 No 4 S Indirect See footnote
Common Stock Disposition 2020-08-10 1,000 $136.37 38,454 No 4 S Indirect See footnote
Common Stock Disposition 2020-08-10 400 $138.70 38,054 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 50,000 Indirect See footnote
Footnotes
  1. The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $133.84 to $134.79, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  3. Includes 1,376 restricted stock units.
  4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $134.85 to $135.84, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $135.85 to $136.79, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  6. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $137.74 to $138.63, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  7. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $138.74 to $139.17, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  8. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $133.95 to $134.82, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  9. Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
  10. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $134.96 to $135.95, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  11. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $135.96 to $136.65, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  12. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $138.57 to $139.06, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  13. Shares held by Michael DeMane Trustee, Michael F. DeMane 2016 Retailed Annuity Trust U/A/D May 22, 2017.